A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics

Summary

To study the pharmacokinetic characteristics of TQ-B3456 in the human body, recommend a reasonable regimen for subsequent research.

Timeline

Start

2020-09-24

Primary completion

2022-02-28

Completion

2022-02-28

Outcome

Outcome not reported

Stopped: “The enrolment task cannot be gotten within the planned time.It mainly includes patients with non-small cell lung cancer failed in standard treatment,with a short survival period.It is hard to obtain observational endpoints for bone-related events.”

Drugs

Indications